Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2021-03-30 | Sumitomo Chemical Co., Ltd. | Urovant Sciences Ltd. | 22,963,479 | 100.0% | EDGAR |
SC 13G/A | 2021-02-16 | PERCEPTIVE ADVISORS LLC | Urovant Sciences Ltd. | 3,116,831 | 9.8% | EDGAR |
SC 13D/A | 2020-11-12 | Sumitomo Chemical Co., Ltd. | Urovant Sciences Ltd. | 22,963,263 | 72.4% | EDGAR |
SC 13G/A | 2020-02-14 | PERCEPTIVE ADVISORS LLC | Urovant Sciences Ltd. | 2,406,931 | 7.9% | EDGAR |
SC 13D | 2020-01-03 | Sumitomo Chemical Co., Ltd. | Urovant Sciences Ltd. | 22,860,013 | 75.2% | EDGAR |
SC 13D/A | 2019-12-31 | Roivant Sciences Ltd. | Urovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-11-04 | Roivant Sciences Ltd. | Urovant Sciences Ltd. | 22,860,013 | 75.4% | EDGAR |
SC 13D/A | 2019-09-06 | Roivant Sciences Ltd. | Urovant Sciences Ltd. | 22,860,013 | 75.4% | EDGAR |
SC 13D/A | 2019-07-17 | Machado Patrick | Urovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-07-17 | Lo Andrew | Urovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-07-16 | Roivant Sciences Ltd. | Urovant Sciences Ltd. | 22,860,013 | 75.4% | EDGAR |
SC 13D/A | 2019-07-12 | VIKING GLOBAL INVESTORS LP | Urovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-07-12 | Dexxon Holdings Ltd. | Urovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-07-12 | SVF Investments (UK) Ltd | Urovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-07-12 | QVT Financial LP | Urovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13G | 2019-06-24 | PERCEPTIVE ADVISORS LLC | Urovant Sciences Ltd. | 1,598,277 | 5.3% | EDGAR |
SC 13D/A | 2019-01-03 | VIKING GLOBAL INVESTORS LP | Urovant Sciences Ltd. | 22,703,669 | 75.6% | EDGAR |
SC 13D | 2018-10-10 | VIKING GLOBAL INVESTORS LP | Urovant Sciences Ltd. | 22,703,669 | 75.6% | EDGAR |
SC 13D | 2018-10-10 | Roivant Sciences Ltd. | Urovant Sciences Ltd. | 22,703,669 | 75.6% | EDGAR |
SC 13D | 2018-10-10 | Machado Patrick | Urovant Sciences Ltd. | 22,703,669 | 75.6% | EDGAR |